SURI – Simplify Propel Opportunities ETF
Simplify Propel Opportunities ETF (SURI) is a Health ETF, issued by Simplify Asset Management, $78.7M in assets, 2.51% expense ratio.
Returns as of Oct 23, 2026: 1 week +0.0%, 1 year +27.2%.
Actively managed, concentrating in biotechnology, pharmaceuticals, healthcare technology, and life sciences. Employs multi-asset strategy across various security types.
Top holdings
- PAGP – Plains GP Holdings LP, 32.3%
- ACHV – Achieve Life Sciences Inc, 7.8%
- PHAT – Phathom Pharmaceuticals Inc, 7.1%
- VRDN – Viridian Therapeutics Inc, 4.3%
- MIST – Milestone Pharmaceuticals Inc, 4.0%
- DCTH_old – Delcath Systems Inc, 3.5%
- ABEO – Abeona Therapeutics Inc, 3.5%
- CLDX – Celldex Therapeutics Inc, 3.1%
- CMPS – Compass Pathways Plc, 2.7%
- OCS – Oculis Holding AG Ordinary shares, 2.6%
- KYTX – Kyverna Therapeutics, Inc. Common Stock, 2.4%
- IVA – Inventiva Sa, 2.1%
- NKTR – Nektar Therapeutics, 1.6%
- RGNX – Regenxbio Inc, 0.7%
- KMPH – KemPharm Inc, 0.4%
- LENZ – LENZ Therapeutics Inc, 0.4%
- 2EB0 – QUOIN PHARMACEUT.ADR5000, 0.3%
- KLRS – Kalaris Therapeutics, Inc., 0.2%
- AARD – Aardvark Therapeutics, Inc. Common Stock, 0.0%